Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 170   

Articles published

BMY 60.20 +0.68 (1.14%)
price chart
3 Reasons Bristol-Myers Squibb Co Stock Could Rise
Public outcry over prescription drug expenses, a strong dollar, and a general pullback in the broader market have the SPDR S&P Pharmaceuticals index off more than 34% over the past six months.
Bristol-Myers Squibb Co (BMY) Stake Held by Community Bank of Raymore  Financial Market News
Bristol-Myers Squibb Co (BMY) Lowered to Hold at TheStreet
Bristol-Myers Squibb Co logo TheStreet downgraded shares of Bristol-Myers Squibb Co (NYSE:BMY) to a hold rating in a research report released on Monday, MarketBeat.
Is Bristol-Myers Squibb Co (NYSE:BMY) Still Struggling to Survive?  Street Report
Bristol-Myers Squibb Co (BMY) Shares Sold by AT Bancorp  Zolmax
Jefferies Group Brokers Increase Earnings Estimates for Bristol-Myers Squibb ...
Bristol-Myers Squibb logo Bristol-Myers Squibb Co (NYSE:BMY) - Analysts at Jefferies Group upped their FY2017 earnings estimates for Bristol-Myers Squibb in a report released on Friday, according to Zacks Investment Research.
Credit Suisse Trims Bristol-Myers Squibb Co (BMY) Target Price to $78.00  The Vista Voice
Bristol-Myers Squibb Company (NYSE:BMY) Had Its PT Decreased by 7.25% at ...  WallStreet.org
Bristol-Myers Squibb Co (BMY) Stock Rating Upgraded by Vetr Inc.
Bristol-Myers Squibb logo Bristol-Myers Squibb Co (NYSE:BMY) was upgraded by research analysts at Vetr from a “buy” rating to a “strong-buy” rating in a note issued to investors on Wednesday, MarketBeat reports.
Trade-Ideas: Bristol-Myers Squibb Company (BMY) Is Today's Unusual ...  TheStreet.com
Bristol-Myers Squibb Co (BMY) Receives Buy Rating from William Blair  Zolmax
3570 Shares in Bristol-Myers Squibb Co (BMY) Acquired by M. Kraus & Company
Bristol-Myers Squibb logo M. Kraus & Company acquired a new position in Bristol-Myers Squibb Co (NYSE:BMY) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Bristol-Myers Squibb Co. (BMY) is Trading Lower on Unusual Volume for January 18  Equities.com
Bristol-Myers Squibb Co (BMY) Stake Lowered by Grassi Investment Management  Zolmax
UPDATE: Berenberg Upgrades Bristol-Myers Squibb Co. (BMY) to Buy
Berenberg upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Hold to Buy with a price target of $77. Analyst Laura Sutcliffe said Bristol-Myers is in a very good place to deliver strong growth in the medium term.
BMO Downgrades Whole Foods And Bristol-Myers Squibb To Start Week: Why?
Whole Foods Market, Inc. (NASDAQ: WFM) shares have lost 12 percent since December 28, while shares of Bristol-Myers Squibb Co (NYSE: BMY) are down 7 percent. BMO Capital Markets analysts downgraded the ratings and reduced the price targets of ...
Charter Trust Company Has $3222000 Position in Bristol-Myers Squibb Co (BMY)  EMQ
Union Bankshares Has $295000 Position in Bristol-Myers Squibb Co (BMY)  Zolmax
BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform
BMO Capital downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Outperform to Market Perform with a price target of $70.00 (from $74.00), saying the risk/reward is balanced here.
Momentum Rating: Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company (NYSE:BMY) has reserved a top momentum style rating from Zacks Research. The momentum rating acts as an important barometer to show as to when a stock will attain a favourable position, which will provide a window of ...
Key Stocks of the Day: Bristol-Myers Squibb Company (NYSE:BMY)
As it reflects the theoretical cost of buying the company's shares, the market cap of Bristol-Myers Squibb Company (NYSE:BMY) is currently rolling at 101298.57, making it one of the key stocks in today's market.